本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Portage Biotech Inc.

7.40
-0.5899-7.38%
成交量:3.12萬
成交額:23.36萬
市值:1,217.65萬
市盈率:-0.12
高:7.75
開:7.22
低:7.22
收:7.99
資料載入中...
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/23

關聯方擬減持公告

Form 144 | Portage Biotech 董事 Steven Mintz 擬減持7577股,總價約12.1萬美元
2024/09/20

關聯方擬減持公告

Form 144 | Portage Biotech董事 Gregory Bailey擬減持7萬股,總價約123萬美元
2024/08/14

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/04

SEC問詢函

Form CORRESP - Correspondence
2023/11/01

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/07/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/04

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/07/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/26

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/05

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/12/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]